-Korea's first online and offline clinical trial brokerage service
-One-stop convenient service for IRB reviews and recruitments of participants

These days, all of our social issues seem to be connected toCOVID-19 one way or another. Due to the COVID-19 outbreak that is lastinglonger than anyone had expected, the world is suffering from social andeconomic hardships, not to mention the broken balance of life on a personallevel. Everyone is wishing for COVID-19 vaccine and treatment drugs to come outas soon as possible, and the pharmaceutical and research institutes from allover the world are all geared towards the development of COVID-19 beaters. Todevelop vaccines and treatments, the safety and effectiveness of candidatedrugs must be demonstrated through non-clinical and clinical trials. Fordiseases like COVID-19, the clinical trials must be conducted in anon-face-to-face method, so a higher reliability from relevant institutions isrequired.

CEO Lee Jeong-hee who runs the clinical trial support platformAllLiveC said, “To commercialize the treatment drugs, we have to run Phase 1-3of the clinical trials in humans. And, for infectious diseases like COVID-19,the contact between the subjects and the investigators should be minimized, sowe have many restrictions in recruitment and the clinical trial process."AllLiveC is a platform operated by AllLive Healthcare, Korea's no. 1 clinicaltrial support service provider. It is providing the clinical trialonline/offline integrated brokerage service that connects applicants who want toparticipate and the clinical trial centers.

Clinical trial is the most important process in the developmentof new drugs, and a huge amount of time and money is spent. AllLive Healthcarehas the goal to innovate these clinical trials with IT technology, and as thefirst step, it has made the platform that provides the service of recruitingand managing the subjects for clinical trials. By using the IT technology, therecruitment of clinical trial subjects that had been conducted manually is doneby AllLiveC, the clinical online/offline clinical trial brokerage service. Itis announcing the clinical trials by online media.

Under the motto of “becoming the chain that links the beginningand the end of new drug development and clinical trials,” AllLive Healthcarewas established in 2015. Its main business targets are mainly thepharmaceutical companies known as the sponsor, clinical trial centers known asthe CRO, hospitals, and participants known as clinical trial applicants(patients, healthy subjects). To maximize the efficiency of recruitment, aprofessional call center is used. The company also provides other convenientservices like total PR media planning and operation, preparatory work for IRBreviews, recruitment of participants, and analysis of the advertising media inits packaged solution AllLiveC One-stop Service.

CEO Lee has witnessed many failures of startups as he was incharge of incubation and acceleration that discover and develop startupcompanies. He emphasizes that for the companies to enter the market withstability and continue to grow, market trends should be interpreted accurately.He is continuously investing in IT-based R&D to expand the efficiency andconvenience of conducting clinical trials in line with market trends. Along withthis, he is developing his own competitiveness of AllLive Healthcare byidentifying the market trend and using an innovative expert group to lead themarket and the experience of working with 100 pharmaceutical companies and 150clinical trial centers.

In clinical trials for infectious diseases such as COVID-19,AllLiveC, a smart clinical trial support platform that uses the technology of anon-face-to-face automated consent system shows its true value. He explains,“We have continued the research of integrating non-face-to-face technology toclinical trials since 2018. We have completed the technology development fornon-face-to-face automated consent system, and it can be used in COVID-19clinical trials right away.”

AllLive Healthcare has been developed in a multilingual versionlast year, and a pilot project is being conducted in Singapore. Lee says,“There is a limit to expanding business in the global market with applicationsalone. That’s why we are planning to connect fully automated or remote clinicalsystems to the application before entering the overseas market.” The company’sgoal is to take one step up from the business that just recruits and managesclinical trial applicants, and evolve as the company that provides a remoteclinical trial system by combining the IT and AI technologies. It has the dreamto become a “Digital CRO” that continuously improves the efficiency of theclinical trial industry by acting as the pharmaceutical companies andhospitals, and supporting the clinical trial faster and more accurately.

For AllLive Healthcare, being located in Pangyo not onlyprovides the geographical advantage of being the center of the metropolitanarea, but also the chance to receive infinite opportunities of cooperation byhaving IT companies of various fields and bio companies close by. Lee thinks,"Pangyo is a place of integration between the IT ecosystem and the bioecosystem, which makes this place the best place to start the business. Also,relevant organizations lie Korea Bio is also located in Pangyo, so we areutilizing it for networking. Not only that, we also have the advantage ofrecruiting great human resources like the developers and designers."